Related Experiment Video
Updated: Dec 6, 2025

09:32
Optimized Analysis of Proteins from Xenopus Oocytes and Embryos by Immunoblotting
Published on: September 19, 2025
316
Confirming Antibody Specificity in Xenopus
Sian A Martin1, Suzannah J Page1, Maya Z Piccinni2
1Molecular Embryology Laboratory, University of Portsmouth, Portsmouth, Hampshire PO1 2DY, United Kingdom.
Cold Spring Harbor Protocols
|October 10, 2020
Summary
Confirming antibody specificity in Xenopus embryos is challenging. This protocol uses CRISPR-Cas9 or mRNA injection with Western blotting to verify antibody recognition of target proteins.
Area of Science:
- Developmental Biology
- Molecular Biology
- Immunology
Background:
- Antibody specificity is crucial for accurate biological research.
- Verifying antibody recognition of target proteins in model organisms can be complex.
Purpose of the Study:
- To present a straightforward protocol for confirming antibody specificity in Xenopus embryos.
- To provide a reliable method for validating antibody-target interactions.
Main Methods:
- Utilizing CRISPR-Cas9 technology to knock down zygotic protein expression.
- Employing microinjection of synthetic mRNA to enhance maternal protein expression.
- Performing Western blotting analysis on Xenopus embryos.
Main Results:
- A weak band on Western blot indicates successful knockdown of the target protein.
- A strong band on Western blot indicates successful enhancement of the target protein.
- Differential band intensity confirms antibody specificity.
Conclusions:
- This protocol offers a powerful strategy for antibody validation in Xenopus.
- The method is effective for both zygotic and maternal proteins.
- Ensures reliable antibody-target binding confirmation.

